Pharmaceutical Business review

R-Squared Enters Into Strategic Partnership With IMS Health

Under the terms of the alliance, R-Squared’s SpendTracker compliance application platform will be implemented to support IMS’ new Aggregate Spend Compliance Services. R-Squared claimed that SpendTracker is a flexible technology purposefully designed for aggregate spend compliance.

The consolidation of IMS’ data sets and its patent-pending dynamic linking results in lot of analytical and operational uses of the data. IMS, through the alliance, will offer implementation, hosting, analytics, master data management, and a range of support services for SpendTracker implementations and aggregate spend compliance, depending on different needs of the client.

Don Otterbein, general manager of business transformation services for IMS, said: IMS evaluated a number of companies, ultimately selecting R-Squared to support our aggregate spend solution because of their strong technology platform. Through this alliance, we will be able to leverage our industry-leading reference data, advisory services, and data management capabilities to deliver an accurate view of spend associated with the healthcare professional.

Michael Bell, President and CEO of R-Squared, said: By aligning with a genuine industry leader, we bring together R-Squared’s strength in creating easy-to-use and configurable compliance software with IMS’s unique combination of global information, analytics, and consulting services to offer unparalleled compliance services for the life sciences industry. This is iron-clad compliance plus business intelligence, and is truly a unique and highly valuable offering.

R-Squared, through patent-pending extensions to Microsoft SharePoint, has developed solutions that it claims are configurable, cost-effective, integrate seamlessly with existing workflows and software systems, prevent costly errors from happening, and maintain evidence of compliance.